Every day clinicians and scientists at the Boris Family Clinic help people deal with their diabetes and look for new solutions to this common disease. Now they are using a novel approach: a music video...[Read more...]
Clinicians and researchers are preparing to light Oxford's Magdalen Tower blue to mark World Diabetes Day - and have invited patients and visitors to then learn more at an open day about the condition at the Churchill Hospital.
The tower at Magdalen College in High Street will follow in the footsteps of other landmarks including Elizabeth Tower (known informally as Big Ben) and Sydney Opera House by turning blue between 4.30pm and 10pm on Monday, November 14, World Diabetes Day...
Few data are available on the potential benefits that achieving different HbA1c targets might deliver. Dr Samiul Mostafa, a Diabetes Trials Unit academic clinical lecturer, used the UKPDS Outcomes Model to estimate 10-year risks for micro- and macrovascular type 2 diabetes complications when targeting HbA1c levels between 10% and 6%, to quantify the likely incremental benefits...[Read more...]
In a landmark report released on 14th September 2016, the United Nations called on governments worldwide to pass legislation requiring clinical trials to be registered, and their methods and results to be fully reported. The report, authored by a high-level panel appointed by UN Secretary General Ban Ki-moon, explicitly calls for clinical trial study designs, protocols, data sets, and test results to be made publicly available...[Read more...]
RDM researchers have uncovered new genetic evidence of how the benefits of the world's most commonly used Type 2 diabetes drug may vary between individuals.
Metformin, a drug used by hundreds of millions of people with Type 2 diabetes worldwide, has been in use for over 50 years...
The International Consortium of Investigators for Fairness in Trial Data Sharing have published a response to the The International Committee of Medical Journal Editors (ICMJE) proposed plan for sharing data from randomized, controlled trials (RCTs). This plan will require, as a condition of acceptance of trial results for publication, that authors make publicly available the deidentified individual patient data underlying the analyses reported in an article...[Read more...]
Dr Samiul Mostafa, DTU Honorary Clinical Lecturer, has received funding from The Academy of Medical Sciences for his project "Determining the 'sweet-spots' for cardiovascular risk factors in Type 2 Diabetes Mellitus
An article in the Summer edition of Diabetes Update highlights the importance of reducing cardiovascular risk in people with diabetes using data from recent clinical outcome trials, several of which were conducted by the Oxford Clinical Trial Service Unit and by the Diabetes Trials Unit[View the PDF]
Following on from the recent highly-successful EXSCEL investigator meetings in Shanghai, Seoul, and Rio de Janeiro, further meetings were held this week for US and Canadian sites in Denver, US, and for European sites in Riga, Latvia. In Denver there were 89 attendees with a further 70 people online, while 142 folk came to Riga...[Read more...]
The NIHR has produced a video highlighting the role that Clinical Trials Units (CTUs) play in developing an NIHR funding application, explaining both the role and benefits of working with CTUs.
CTUs are specialist units which have been set up with a specific remit to design, conduct, analyse and publish clinical trials...
The first edition of the 2016 TRG newsletter is now available. Click the link below to find out about our work and recent activities[View the PDF]